Electronic health records to facilitate continuous detection of familial hypercholesterolemia
Affiliations
- PMID: 32927124
- DOI: 10.1016/j.atherosclerosis.2020.07.022
Abstract
Background and aims: Familial hypercholesterolemia (FH) is an inherited disorder associated with increased risk of coronary heart disease as a result of high LDL-cholesterol (LDL-C). The clinical diagnosis can be made with the Dutch Lipid Clinic Network criteria (DLCN criteria). FH is an underdiagnosed disorder, possibly due to false negative LDL-C interpretation during lipid lowering therapy (LLT). We hypothesized that automated health record-based integration of data can provide a signal to facilitate identification of FH patients.
Methods: We included patients with LDL-C ≥6.5 mmol/l after correction for LLT in all patients testing LDL-C in Northwest Clinics, The Netherlands. Patients previously diagnosed with FH were excluded. The primary endpoint was the additional number of patients with DLCN criteria ≥6 points after correction for LLT. Secondary endpoints were the additional number of patients with DLCN criteria ≥6 points after also adding data on patient- and family history, and LDL-C before and after correction for LLT. Analysis was performed in a daily automated routine (HiX ChipSoft).
Results: In a total of 41,937 individual LDL-C measurements during 26 weeks, we found 351 patients with LDL-C ≥6.5 mmol/l after automated correction for LLT. FH had previously been diagnosed in 42 patients. In the remaining 309 patients (58.3% female; age: 66 ± 11 yrs (mean ± SD); 85.8% on LLT), the number of patients with DLCN criteria ≥6 points increased from 9 to 95 after correction for LLT, and to 127 after also adding patient and family history. The mean LDL-C before and after correction for LLT was 4.69 ± 1.42 mmol/l and 8.16 ± 1.68 mmol/l, respectively (mean ± SD; p < 0.001).
Conclusions: We conclude that automated medical record-based integration of LDL-C, LLT and patient- and family history can provide a crucial signal to facilitate identification of FH. Whether this signal results in subsequent genetic identification of FH patients and their relatives requires further study.
Keywords: Algorithm; Electronic health records (EHRs); Familial hypercholesterolaemia; LDL-Cholesterol.
Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.
Similar articles
- Low-density lipoprotein apheresis: an evidence-based analysis.Ont Health Technol Assess Ser. 2007;7(5):1-101. Epub 2006 Nov 1.PMID: 23074505 Free PMC article.
- Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217.Eur Heart J. 2016 May 1;37(17):1384-94. doi: 10.1093/eurheartj/ehw028. Epub 2016 Feb 22.PMID: 26908947
- Familial Hypercholesterolemia.2014 Jan 2 [updated 2016 Dec 8]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020.PMID: 24404629 Free Books & Documents. Review.
- Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway.J Clin Lipidol. 2018 Mar-Apr;12(2):375-382. doi: 10.1016/j.jacl.2017.11.009. Epub 2017 Dec 6.PMID: 29310990
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.Eur Heart J. 2015 Sep 21;36(36):2425-37. doi: 10.1093/eurheartj/ehv157. Epub 2015 May 25.PMID: 26009596 Free PMC article. Review.
No hay comentarios:
Publicar un comentario